Correction To: Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions

Affiliations

¹ Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
² Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. tiands@tjh.tjmu.edu.cn.
³ Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. wwang@tjh.tjmu.edu.cn.

^# Contributed equally.

Published Erratum

Chuan Qin et al. Signal Transduct Target Ther. 2022.

. 2022 Aug 12;7(1):278.

doi: 10.1038/s41392-022-01129-1.

¹ Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
² Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. tiands@tjh.tjmu.edu.cn.
³ Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. wwang@tjh.tjmu.edu.cn.

^# Contributed equally.

No abstract available

Erratum for

Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions.
Qin C, Yang S, Chu YH, Zhang H, Pang XW, Chen L, Zhou LQ, Chen M, Tian DS, Wang W. Qin C, et al. Signal Transduct Target Ther. 2022 Jul 6;7(1):215. doi: 10.1038/s41392-022-01064-1. Signal Transduct Target Ther. 2022. PMID: 35794095 Free PMC article. Review.

1. Qin C, Yang S, Chu YH, et al. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Sig. Transduct. Target. Ther. 2022;7:215. doi: 10.1038/s41392-022-01064-1. - DOI - PMC - PubMed